PetVivo Holdings, Inc.
PETV- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001512922
In the last 90 days, PetVivo Holdings, Inc. insiders filed 2 open-market purchases and 0 sales; 1 institution reported holding it in 13F filings for Q2 2026, worth $40.4K in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 8, 2026, 1:22 PM ET
Revenue flow, FY2026
Where the revenue went in FY2026, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net loss for FY2026: $10.5M (917.4% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Period end | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | – | – | Jun 28, 2024 | Jun 29, 2023 | – |
| Revenue | $1.14M | $1.13M | $968.7K | $917.2K | $115.6K |
| Cost of revenue | $386.9K | $137.7K | $229.2K | $526.8K | $201.2K |
| Gross profit | $754.8K | $994.9K | $739.5K | $390.3K | -$85.6K |
| Operating expenses | $9.82M | $9.05M | $11.4M | $9.12M | $4.97M |
| Research and development | $1.42M | $1.58M | $1.27M | $690.6K | $474.9K |
| Selling, general and administrative | $4.33M | $4.82M | $6.69M | $5.02M | $3.15M |
| Operating income | -$9.06M | -$8.06M | -$10.6M | -$8.73M | -$5.06M |
| Interest expense | $12.7K | – | – | – | – |
| Net income | -$10.5M | -$8.40M | -$11.0M | -$8.72M | -$5.01M |
| EPS, basic | $-0.38 | $-0.41 | $-0.78 | $-0.85 | $-0.57 |
| EPS, diluted | $-0.38 | $-0.41 | $-0.78 | – | – |
| Weighted shares, basic | 30.2M | 20.5M | 14.0M | 10.2M | 8.76M |
| Weighted shares, diluted | 30.2M | 20.5M | 14.0M | – | – |
| Margins and growth | |||||
| Gross margin | 66.1% | 87.8% | 76.3% | 42.6% | -74.0% |
| Operating margin | -793.9% | -711.3% | -1096.4% | -952.2% | -4374.7% |
| Net margin | -917.4% | -741.6% | -1130.9% | -950.5% | -4338.8% |
| Revenue growth, year over year | +0.8% | +16.9% | +5.6% | +693.5% | +819.0% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Period end | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | – | – | Jun 28, 2024 | Jun 29, 2023 | – |
| Cash and equivalents | $200.8K | $227.7K | $87.4K | $475.3K | $6.11M |
| Short-term investments | $150.0K | – | – | – | – |
| Accounts receivable | $100.8K | $60.6K | $18.7K | $86.7K | $2.60K |
| Inventory | $538.4K | $323.5K | $390.1K | $370.3K | $98.3K |
| Total current assets | $1.86M | $5.61M | $1.04M | $1.42M | $6.76M |
| Property, plant and equipment | $448.9K | $766.9K | $821.7K | $630.9K | $311.5K |
| Intangible assets | $20.5K | $23.7K | $30.1K | $38.6K | $48.5K |
| Total assets | $3.58M | $9.34M | $3.12M | $2.44M | $7.43M |
| Accounts payable | $547.4K | $821.1K | $821.2K | $588.7K | $323.4K |
| Total current liabilities | $1.38M | $4.32M | $1.41M | $1.45M | $1.17M |
| Total liabilities | $1.38M | $5.12M | $2.43M | $1.71M | $1.44M |
| Shareholders' equity | $2.20M | $4.22M | $686.0K | $725.0K | $5.99M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Period end | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | – | – | Jun 28, 2024 | Jun 29, 2023 | – |
| Operating cash flow | -$6.11M | -$5.32M | -$7.42M | -$6.79M | -$4.17M |
| Capital expenditures | $7.73K | $63.4K | $309.1K | $423.9K | $154.0K |
| Free cash flow | -$6.12M | -$5.39M | -$7.73M | -$7.22M | -$4.33M |
| Depreciation and amortization | $511.5K | $174.6K | $126.8K | $114.4K | $65.2K |
| Stock-based compensation | $1.88M | $1.11M | $2.11M | $1.46M | $702.9K |
| Investing cash flow | $11.8K | -$563.4K | -$309.1K | -$423.9K | -$183.2K |
| Financing cash flow | $6.07M | $6.03M | $7.34M | $1.59M | $10.4M |
| Net change in cash | -$26.9K | $140.3K | -$387.9K | -$5.63M | $6.08M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 164.7% | 97.8% | 217.8% | 159.5% | 608.1% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Aug 14, 2026 | 38.0M | +36.0% | SEC |
| Jun 29, 2026 | 37.6M | +54.1% | SEC |
| Feb 17, 2026 | 35.0M | +57.7% | SEC |
| Nov 14, 2025 | 33.6M | +61.0% | SEC |
| Aug 14, 2025 | 27.9M | +39.5% | SEC |
| Jul 10, 2025 | 24.4M | +22.5% | SEC |
| Feb 14, 2025 | 22.2M | +32.4% | SEC |
| Nov 14, 2024 | 20.9M | +44.2% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.